Table 2 Comparison of DIALOGUE with other existing registries
| DIALOGUE | DiaRegis | DIG | DUTY | |
|---|---|---|---|---|
| Reference | [2, 38–40] | [35–37] | [34] | |
| No. of physicians | Up to 700 | 313 | 238 | n.a. |
| No. of patients | Up to 10,000 | 3,810 | 4,020 | 59,035 |
| Recruitment | Starting 06/2012 | 06/2009–03/2010 | 2002-2004 | 2001-2003 |
| Follow-up | 2-4 years | 2 years | 4 years | 9 months |
| Design | Prospective cohort | Prospective cohort | Prospective cohort study | Prospective cohort study |
| Monitoring for data verification | Yes (2%) | Yes (10%) | None | None |
| Proportion T2D | 100% | 100% | 100% | 100% |
| Patients | Co-morbid disease of diabetes and hypertension | Patients on oral mono- or dual antidiabetic combination therapy | Type-2 Diabetes mellitus | Type-1 or type-2 diabetes mellitus |
| Median age (years) | n.a. | 65.9 | Mean 61.8 ± 8.1 | 64.4 ± 11.7 |
| Female (%) | n.a. | 46.7 | 46.8 | 50.9 |
| BMI (median) | n.a. | 30.0 | Mean 30.7 ± 5.2 | Mean 28.7 ± 4.8 |
| Focus | Target achievement with respect to HbA1c and blood pressure | Hypoglycaemia incidence with antidiabetic drug use | Application of guidelines in clinical practice | Effect of tailored intervention on target achievement |